Ye, S., Zhao, X., Hu, X., Li, T., Xu, Q., Yang, H., . . . Yang, L. (2017). TP53 and RET may serve as biomarkers of prognostic evaluation and targeted therapy in hepatocellular carcinoma. Oncol Rep.
Citação norma ChicagoYe, Song, Xin-Yi Zhao, Xiao-Ge Hu, Tang Li, Qiu-Ran Xu, Huan-Ming Yang, Dong-Sheng Huang, and Liu Yang. "TP53 and RET May Serve As Biomarkers of Prognostic Evaluation and Targeted Therapy in Hepatocellular Carcinoma." Oncol Rep 2017.
Citação norma MLAYe, Song, et al. "TP53 and RET May Serve As Biomarkers of Prognostic Evaluation and Targeted Therapy in Hepatocellular Carcinoma." Oncol Rep 2017.
Nota: a formatação da citação pode não corresponder 100% ao definido pela respectiva norma.